Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-20-056222

Director acquired 2,057 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

PATOU GARY · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-10-28 Exercise or conversion : show line 1 in the form +2,057 $3.76 $7,734 23,573 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-10-28 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −2,057 0 D
Loading xslF345X03/doc4.xml…